Document is current
Any future updates will be listed below
-
Authors
Pott, Henrique
LeBlanc, Jason J.
ElSherif, May
Hatchette, Todd F.
McNeil, Shelly A.
Andrew, Melissa K.
,
Boivin, Guy
Trottier, Sylvie
Diaz-Mitoma, Francisco
Verschoor, Chris
Stiver, Grant
Bowie, William
Green, Karen
McGeer, Allison
Johnstone, Jennie
Loeb, Mark
Katz, Kevin
Lagacé-Wiens, Phillipe
Light, Bruce
McCarthy, Anne
Poirier, Andre
Powis, Jeff
Richardson, David
Semret, Makeda
Smith, Stephanie
Taylor, Geoff
Smyth, Daniel
Valiquette, Louis
Webster, Duncan
- License Information
-
More Information
Article History
Received: 16 October 2023
Accepted: 17 July 2024
First Online: 8 August 2024
Competing interests
: HP reports grant funding from Coordenação de Aperfeiçoamento de Pessoal de Nível Superior—Brasil (CAPES)—Finance Code 001. TFH reports grants from Pfizer and GSK outside the submitted work. SAM reports grants and payments from Pfizer, GSK, Merck, Novartis, and Sanofi outside the submitted work. MK Andrew reports grant funding from the GSK group of companies, Pfizer and Sanofi Pasteur, and honoraria for past ad-hoc advisory activities from Pfizer, Sanofi, and Seqirus, all unrelated to the present manuscript. JL and ME report no conflicts of interest.
